期刊文献+

艾司西酞普兰与帕罗西汀治疗抑郁症的临床对照研究 被引量:2

A case-control study of citalopram and paroxetine in the treatment of depression
下载PDF
导出
摘要 目的比较艾司西酞普兰与帕罗西汀治疗抑郁症的有效性和安全性。方法将在精神科治疗病例随机分为艾司西酞普兰组和帕罗西汀组,应用汗密顿抑郁量表(HAMD)(17项)评定治疗效果,应用副反应量表(TESS)评定不良反应,在入院时、1、2、4周分别进行对照,分别完成43、44例。结果研究终点两组疗效显示:艾司西酞普兰组有效率为83.7%,帕罗西汀组有效率为86.4%,两组有效率无统计学差异(P>0.05),但艾司西酞普兰起效要快,2周时艾司西酞普兰组的HAMD减分率较帕罗西汀组明显(P<0.05);艾司西酞普兰副作用要少,但共有副作用两者发生率无显著性差异(P>0.05)。结论艾司西酞普兰治疗抑郁症疗效与帕罗西汀相当,但起效要快、不良反应要少,是治疗抑郁症的较好选择。 Objective To explore the validity and safe of Citalopram and Paroxetine in treatment of depression. Methods The cases were divide To into Citalopram group and Paroxetine group at random. Hamilton Rating Scale for Depression and Treatment Emergent Symptom Scale were used to assess the patients with Depressive Disorder. Results There was no significant difference between two groups in the effective power. The Citalopram group got the significantly faster curative effect as compare with the subjects of the Paroxetine group. The Citalopram group had less adverse reaction as compare with the subjects of the Paroxetine group, but the difference was not significant. Conclusion Citalopram has the same curative effect as Pamxetine, but Citalopram has the superiority of earlier curative effect and less adverse reaction than Paroxetine in the Treatment of Depression.
出处 《湘南学院学报(医学版)》 2011年第1期15-17,共3页 Journal of Xiangnan University(Medical Sciences)
关键词 艾司西酞普兰 帕罗西汀 抑郁症 HAMD TESS Citalopram Paroxetine Depression HAMD TESS
  • 相关文献

参考文献5

  • 1王进祥,杨海波.西酞普兰与帕罗西汀治疗抑郁症的对照研究[J].吉林医学,2007,28(15):1648-1649. 被引量:7
  • 2钱敏才,沈鑫华,林敏.艾司西酞普兰与舍曲林治疗门诊抑郁症的对照研究[J].上海精神医学,2007,19(2):95-97. 被引量:51
  • 3Plenge P,Mellerup ET, Laursen H. Affinity modulation of [3H] imipramine, [3H] paroxetine and [ 3HI citalopram binding to the 5 - HT transporter from brain and platelets [ J]. Eur J Pharmacol, 1991,206 : 243 - 250.
  • 4SANCHEZ C, BERGQVIST PB, BRENNUM LT, et al. Escitalo - pram, the S - ( + ) - enantiomer of citalopram , is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities [J]. Psy- chophar macology (Berl), 2003, 167 (4) :353 - 362.
  • 5VON MOLTKELL, GREENBLATF DJ, GIANCARID GM, et al. Escitalopram(S- citalopram) and its metabolites in vitro: cy- tochromes mediating biotransformation, inhibitory effects, and comparison to R- citalopram [J]. Drug Metab Dispos,2001,29 (8):1102- 1109.

二级参考文献6

共引文献54

同被引文献24

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部